| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.07B | +22.1% |
| Cost of Revenue | $625.9M | +16.5% |
| Gross Profit | $1.45B | +24.6% |
| R&D Expense | $219.6M | +7.1% |
| SG&A Expense | $917.2M | +24.8% |
| Operating Income | $308.9M | +40.4% |
| Pre-tax Income | $300.2M | +39.9% |
| Income Tax | -$118.1M | -1522.9% |
| Net Income | $418.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Inventory | $430.4M | +6.9% |
| Current Assets | $1.89B | +19.5% |
| Total Assets | $3.09B | +19.3% |
| Current Liabilities | $528.4M | +17.1% |
| Long-term Debt | $1.30B | -5.1% |
| Total Liabilities | $1.88B | +1.1% |
| Stockholders' Equity | $1.21B | +65.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $430.3M | +195.3% |
| Capital Expenditures | $124.9M | +65.2% |
| Investing Cash Flow | -$146.2M | -22.4% |
| Financing Cash Flow | -$28.1M | -106.6% |
| Free Cash Flow | $305.4M | +335.7% |
| +102.8% |
| EPS (Basic) | $5.97 | +101.7% |
| EPS (Diluted) | $5.78 | +96.6% |